- Home
- / Guangzhou Baiyunshan Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Guangzhou Baiyunshan Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥28.2
2024-10-29
Market Capitalization
¥43.3 B
2024-10-29
Revenue
¥77.1 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 41.7B | 64.4B | 61.2B | 68.5B | 70.3B | 74.9B | 74.5B | 77.1B |
| Cost of goods sold | 32.2B | 52.1B | 51.2B | 55.8B | 57.5B | 61.3B | 62.5B | 65.0B |
| Gross profit | 9.8B | 12.6B | 10.2B | 12.9B | 13.0B | 13.8B | 12.2B | 12.3B |
| Gross profit margin, % | 19.5% | 16.6% | 18.9% | 18.5% | 18.5% | 16.4% | 15.9% | |
| Operating expense total | 6.8B | 8.7B | 7.0B | 8.6B | 8.4B | 8.8B | 8.5B | 8.3B |
| Depreciation and amortization | 930.4M | 369.7M | 378.2M | 410.7M | 609.1M | 653.4M | 620.3M | 677.9M |
| EBITDA | 3.3B | 4.0B | 3.5B | 4.5B | 4.7B | 5.2B | 3.7B | 4.0B |
| EBITDA margin, % | 6.2% | 5.8% | 6.6% | 6.7% | 6.9% | 4.9% | 5.1% | |
| EBIT | 2.7B | 4.0B | 3.4B | 4.4B | 4.5B | 4.8B | 3.4B | 3.5B |
| EBIT margin, % | 6.3% | 5.6% | 6.4% | 6.3% | 6.4% | 4.5% | 4.5% | |
| Interest income | 262.0M | 303.2M | 373.9M | 563.9M | 626.8M | 486.3M | 404.3M | 141.9M |
| Interest expense | 231.6M | 393.6M | 296.6M | 417.8M | 434.4M | 446.2M | 418.2M | 401.5M |
| Pre tax profit | 4.0B | 4.1B | 3.7B | 4.7B | 5.0B | 5.1B | 3.6B | 3.7B |
| Income tax expense | 485.0M | 687.2M | 647.5M | 754.1M | 789.9M | 851.2M | 606.8M | 629.2M |
| Net Income | 3.5B | 3.4B | 3.1B | 4.0B | 4.3B | 4.3B | 3.0B | 3.1B |